製品名:2,4-Difluorophenylacetic acid

IUPAC Name:2-(2,4-difluorophenyl)acetic acid

CAS番号:81228-09-3
分子式:C8H6F2O2
純度:95%+
カタログ番号:CM368839
分子量:172.13

包装単位 有効在庫 価格(USD) 数量
CM368839-50g in stock ʼnǵ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:81228-09-3
分子式:C8H6F2O2
融点:-
SMILESコード:OC(=O)CC1=C(F)C=C(F)C=C1
密度:
カタログ番号:CM368839
分子量:172.13
沸点:
MDL番号:
保管方法:

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Ogsiveo
The FDA has approved Ogsiveo (Nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment. Ogsiveo is the first drug to be approved for the treatment of patients with desmoid tumors, a rare subtype of soft tissue sarcomas. The FDA approval of Ogsiveo is based on the results from the Phase 3 DeFi trial. The results showed that Ogsiveo met the primary endpoint of improving progression-free survival (PFS), demonstrating a statistically significant improvement over placebo with a 71% reduction in the risk of disease progression (hazard ratio (HR) = 0.29 (95% CI: 0.15, 0.55); p< 0.001). Ogsiveo is an oral, selective, small molecule gamma secretase inhibitorγ. Gamma secretase cleaves multiple transmembrane proteins, including Notch, that are believed to play a role in activating pathways that contribute to growth of desmoid and ovarian granulosa cell tumors.